Performance of antinuclear antibody connective tissue disease screen

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 322-329

  López Hoyos, Marcos ^a   Rodríguez Valverde, Vicente ^a   Martinez Taboada, Victor ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antinuclear antibodies; Connective tissue disease; ELISA; Indirect immunofluorescence; Screen

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGED; ANKYLOSING SPONDYLITIS; AUTOIMMUNITY; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GIANT CELL ARTERITIS; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; REACTIVE ARTHRITIS; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SCREENING; SERUM; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; STATISTICAL MODEL; ADOLESCENT; ALGORITHM; ARTICLE; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; ROC CURVE;

ANAS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ROC CURVE;

EID: 34848813912     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.038     Document Type: Conference Paper

References (10)

1. LYONS, R., S. NARAIN, C. NICHOLS, et al. 2005. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann. N. Y. Acad. Sci. 1050: 217-228.
2. SOLOMON, D.H., A.J. KAVANAUGH & P.H. SCHUR. 2002. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 47: 434-444.
3. BERNARDINI, S., M. INFANTINO, L. BELLINCAMPI, et al. 2004. Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay. Clin. Chem. Lab. Med. 42: 1155-1160.
4. LOPEZ-HOYOS, M., R. Cabeza, V.M. M ARTINEZ-TABOADA, et al. 2005. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus. Lupus 14: 505-509.
5. NOSSENT, H. & O.P. REKVIG. 2001. Antinuclear antibody screening in this new millenium: farewell to the microscope? Scand. J. Rheumatol. 30: 123-126.
6. TAN, E.M., A.S. COHEN, J.F. FRIES, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
7. FARIA, A.C., K.S. BARCELLOS & L.E. ANDRADE 2005. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J. Rheumatol. 32: 1267-1272.
8. INVERNIZZI, P., C. SELMI, C. RANFTLER, et al. 2005. Antinuclear antibodies in primary biliary cirrhosis. Semin. Liver Dis. 25: 298-310.
9. ARBUCKLE, M.R., M.T. MCCLAIN, M.V. RUBERTONE, et al. 2003. Development of autoantibodies befote the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349: 1526-1533.
10. NARAIN, S., H.B. RICHARDS, M. SATOH, et al. 2004. Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch. Intern. Med. 164: 2435-2441.